Ilya Sutskever vs Dario Amodei Net Worth: Who's Richer in 2026?

Quick answer

Dario Amodei is richer than Ilya Sutskever — by more than double. Forbes puts Amodei at $15.5 billion on a ~1.7% stake in Anthropic, valued at $965 billion. Sutskever is estimated at roughly $7 billion — a figure anchored in 2026 court testimony about his OpenAI stake, plus his ownership of Safe Superintelligence (SSI), valued at $32 billion. Two ex-OpenAI safety researchers, two labs, two fortunes — and a gap that comes down to one word: revenue.

The comparison is irresistible because the two men are mirror images. Both left OpenAI over safety concerns. Both founded labs to build safe AI. Both are intensely private. But one built a commercial giant and the other a research monastery — and the market prices them $933 billion apart. For Sutskever's full story, see his net worth breakdown; for Amodei's, see Dario Amodei's net worth.

Head to head: the numbers

The headline gap — $15.5B vs ~$7B — tracks the valuation gap between their labs almost exactly. Amodei owns ~1.7% of a $965 billion company; Sutskever owns an undisclosed slice of a $32 billion one plus a legacy OpenAI stake. Anthropic is worth roughly 30x SSI, and Amodei is worth roughly 2.2x Sutskever. The math is consistent.

Two exits from OpenAI, three years apart

The origin stories rhyme. Amodei joined OpenAI as VP of research in 2016 and left in late 2020, taking key safety researchers with him to found Anthropic in 2021 with his sister Daniela — a split driven by disagreements over OpenAI's commercial direction. Sutskever stayed: he was chief scientist through the GPT breakthroughs, ChatGPT, and the reasoning models, and only left in May 2024 after the November 2023 boardroom crisis — in which he first voted to fire Sam Altman, then reversed himself within days.

Amodei's exit was strategic and orderly; Sutskever's was dramatic and public. But both exits had the same root: the belief that AI development needed a safer home than OpenAI was becoming. Amodei built that home in 2021; Sutskever built his in 2024.

Two models: the company vs the monastery

Where they diverge is the business model. Anthropic is a commercial AI company: it ships Claude, signs enterprise deals, generates real revenue, and justifies its $965 billion valuation with a business. SSI is Sutskever's stated opposite: "We will pursue safe superintelligence with a singular focus on one goal and one product" — no products, no benchmarks, no press, no revenue, ~50 employees, and a $32 billion valuation priced purely on investor conviction (Greenoaks, a16z, Alphabet, Nvidia — which added $5 billion in July 2026).

This is the $933 billion question in miniature: does the market pay more for safe AI as a product (Anthropic) or safe AI as a research project (SSI)? So far, product wins — by a factor of 30. Sutskever's bet is that the research monastery eventually produces something the commercial labs can't, and that the $32 billion is early.

Verdict: Amodei wins the fortune, Sutskever keeps the mystique

On the numbers, it's not close: $15.5 billion vs ~$7 billion, and Amodei's figure comes from Forbes while Sutskever's is an estimate built on court testimony and undisclosed ownership percentages. Amodei also has the cleaner structure — a single disclosed-ish stake in a revenue-generating company — where Sutskever's wealth is split across a legacy OpenAI holding and a research lab with no revenue.

But the comparison has a second act still to run. If SSI's secret research produces a breakthrough, $32 billion will look like a rounding error and Sutskever's concentrated founder equity could close the gap fast. Amodei won the first decade of the safety-lab race. Sutskever is betting the second one belongs to the researcher who never stopped believing the breakthrough comes from focus, not product. For the full breakdowns behind these numbers, see Sutskever's net worth and Amodei's net worth.

Frequently asked questions